Serum lipoprotein-associatedv phospholipase A2 and c-reactive protein levels in association with periodontal disease and hyperlipidemia

Journal of Periodontology

Volumn 82, Issue 3, 2011, Pages 350-359

  Fentoǧlu, Özlem ^a   Köroǧlu, Banu Kale ^b   Kara, Yusuf ^c   Doǧan, Burak ^a   Yilmaz, Gülin ^a   Sütçü, Recep ^b   Ay, Zuhal Yetkin ^a   Tonguç, Mine Öztürk ^a   Orhan, Hikmet ^d   Tamer, M Numan ^b   Kirzioǧlu, F Yeşim ^a  

^a SULEYMAN DEMIREL UNIVERSITY   (Turkey)

^b SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c Department of Biochemistry   (Turkey)

^d Unit of Biometry and Genetic   (Turkey)

Author keywords

C reactive protein; Gingivitis; Hyperlipidemia; Lipoproteinassociated phospholipase A2.; Periodontitis

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; AUTACOID; C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID;

ADULT; ARTICLE; BLOOD; CASE CONTROL STUDY; CHRONIC PERIODONTITIS; ENZYMOLOGY; FEMALE; GINGIVITIS; HUMAN; HYPERLIPIDEMIA; LOW FAT DIET; MALE; MIDDLE AGED; NONPARAMETRIC TEST; REGRESSION ANALYSIS;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ADULT; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHRONIC PERIODONTITIS; DIET, FAT-RESTRICTED; FEMALE; GINGIVITIS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS; INFLAMMATION MEDIATORS; LIPIDS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; STATISTICS, NONPARAMETRIC;

EID: 79952788658     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2010.100417     Document Type: Article

References (50)

1. Mattila KJ, Nieminen MS, Valtonen VV, et al. Association between dental health and acute myocardial infarction. BMJ 1989;298:779-781. (Pubitemid 19084520)
2. DeStefano F, Anda RF, Kahn HS, Williamson DF, Russell CM. Dental disease and risk of coronary heart disease and mortality. BMJ 1993;306:688-691. (Pubitemid 23070231)
3. Joshipura KJ, RimmEB, Douglass CW, Trichopoulos D, Ascherio A, Willett WC. Poor oral health and coronary heart disease. J Dent Res 1996;75:1631-1636. (Pubitemid 32763637)
4. Arbes SJ Jr, Slade GD, Beck JD. Association between extent of periodontal attachment loss and self-reported history of heart attack: An analysis of NHANES III data. J Dent Res 1999;78:1777-1782. (Pubitemid 32507623)
5. Hujoel PP. Does chronic periodontitis cause coronary heart disease? A review of the literature. J Am Dent Assoc 2002;133(Suppl.):31S-36S.
6. Haynes WG, Stanford C. Periodontal disease and atherosclerosis: From dental to arterial plaque. Arterioscler Thromb Vasc Biol 2003;23:1309-1311. (Pubitemid 36994513)
7. Hung HC, Willett W, Merchant A, Rosner BA, Ascherio A, Joshipura KJ. Oral health and peripheral arterial disease. Circulation 2003;107:1152-1157. (Pubitemid 36297207)
8. Rutger Persson G, Ohlsson O, Pettersson T, Renvert S. Chronic periodontitis, a significant relationship with acute myocardial infarction. Eur Heart J 2003;24: 2108-2115. (Pubitemid 37486530)
9. Desvarieux M, Demmer RT, Rundek T, et al. Relationship between periodontal disease, tooth loss, and carotid artery plaque: The Oral Infections and Vascular Disease Epidemiology Study (INVEST). Stroke 2003; 34:2120-2125. (Pubitemid 37099823)
10. Desvarieux M, Schwahn C, Völzke H, et al. Gender differences in the relationship between periodontal disease, tooth loss, and atherosclerosis. Stroke 2004; 35:2029-2035. (Pubitemid 39129554)
11. Ross R. Atherosclerosis - An inflammatory disease. N Engl J Med 1999;340:115-126. (Pubitemid 29054847)
12. Cutler CW, Shinedling EA, Nunn M, et al. Association between periodontitis and hyperlipidemia: Cause or effect? J Periodontol 1999;70:1429-1434.
13. Lösche W, Karapetow F, Pohl A, Pohl C, Kocher T. Plasma lipid and blood glucose levels in patients with destructive periodontal disease. J Clin Periodontol 2000; 27:537-541.
14. Lösche W, Karapetow F, Pohl A, Krause S, Kocher T. The plasma lipids, blood glucose as well as PAFacetylhydrolase in destructive periodontitis (in German). Dtsch Zahnarztl Z 2000;55:431-434.
15. Katz J, Chaushu G, Sharabi Y. On the association between hypercholesterolemia, cardiovascular disease and severe periodontal disease. J Clin Periodontol 2001;28:865-868. (Pubitemid 33755449)
16. Katz J, Flugelman MY, Goldberg A, Heft M. Association between periodontal pockets and elevated cholesterol and low density lipoprotein cholesterol levels. J Periodontol 2002;73:494-500. (Pubitemid 34546399)
17. Morita M, Horiuchi M, Kinoshita Y, Yamamoto T, Watanabe T. Relationship between blood triglyceride levels and periodontal status. Community Dent Health 2004;21:32-36. (Pubitemid 38918271)
18. Moeintaghavi A, Haerian-Ardakani A, Talebi-Ardakani M, Tabatabaie I. Hyperlipidemia in patients with periodontitis. J Contemp Dent Pract 2005;6:78-85. (Pubitemid 43093715)
19. Noack B, Jachmann I, Roscher S, et al. Metabolic diseases and their possible link to risk indicators of periodontitis. J Periodontol 2000;71:898-903.
20. Fentoílu O, Oz G, Tasxdelen P, Uskun E, Aykacx Y, Bozkurt FY. Periodontal status in subjects with hyperlipidemia. J Periodontol 2009;80:267-273.
21. Awartani F, Atassi F. Evaluation of periodontal status in subjects with hyperlipidemia. J Contemp Dent Pract 2010;11:33-40.
22. Oz SG, Fentoglu O, Kilicarslan A, et al. Beneficial effects of periodontal treatment on metabolic control of hypercholesterolemia. South Med J 2007;100:686-691. (Pubitemid 47056518)
23. Duan JY, Ou-Yang XY, Zhou YX. Effect of periodontal initial therapy on the serum level of lipid in the patients with both periodontitis and hyperlipidemia (in Chinese). Beijing Da Xue Xue Bao 2009;41:36-39.
24. Fentoílu O, Sözen T, Oz S, et al. Short-term effects of periodontal therapy as an adjunct to anti-lipemic treatment. Oral Dis 2010;16:648-654.
25. 2 with a catalytic triad. J Biol Chem 1995;270:25481-25487.
26. Häkkinen T, Luoma JS, Hiltunen MO, et al. Lipoproteinassociated phospholipase A(2), platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions. Arterioscler Thromb Vasc Biol 1999;19:2909-2917. (Pubitemid 30029817)
27. 2 protein expression in the natural progression of human coronary atherosclerosis. Arterioscler Thromb Vasc Biol 2006;26:2523-2529. (Pubitemid 44607475)
28. 2 is an independent marker for coronary endothelial dysfunction in humans. Arterioscler Thromb Vasc Biol 2006;26:106-111. (Pubitemid 43732235)
29. 2 and plasma lipids in patients with destructive periodontal disease. J Clin Periodontol 2005; 32:640-644. (Pubitemid 40780233)
30. Chang MK, Binder CJ, Torzewski M, Witztum JL. C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids. Proc Natl Acad Sci USA 2002;99:13043-13048.
31. Volanakis JE. Human C-reactive protein: Expression, structure, and function. Mol Immunol 2001;38:189-197. (Pubitemid 32786776)
32. Paraskevas S, Huizinga JD, Loos BG. A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol 2008;35: 277-290.
33. Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-135.
34. Löe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963; 21:533-551.
35. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol 1999;4:1-6.
36. Wakai K, Kawamura T, Umemura O, et al. Associations of medical status and physical fitness with periodontal disease. J Clin Periodontol 1999;26:664-672.
37. Kant AK, Schatzkin A, Graubard BI, Schairer C. A prospective study of diet quality and mortality in women. JAMA 2000;283:2109-2115. (Pubitemid 30241306)
38. Remsberg KE, Rogers NL, Demerath EW, et al. Sex differences in young adulthood metabolic syndrome and physical activity: The Fels longitudinal study. Am J Hum Biol 2007;19:544-550. (Pubitemid 47050088)
39. Naito HK. The association of serum lipids, lipoproteins, and apolipoproteins with coronary artery disease assessed by coronary arteriography. Ann N Y Acad Sci 1985;454:230-238. (Pubitemid 16198855)
40. Maglakelidze N, Galogre A, Tsagareli Z. Functionalmorphologic aspects of changes of mucosal gingiva microcirculatory bed vessels in experimental gingivitis against the background of hypercholesterolemia (in Russian). Georgian Med News 2005;121:71-74.
41. Chait A, Han CY, Oram JF, Heinecke JW. Thematic review series: The immune system and atherogenesis. Lipoprotein-associated inflammatory proteins: Markers or mediators of cardiovascular disease? J Lipid Res 2005;46:389-403.
42. Cutler CW, Kalmar JR, Genco CA. Pathogenic strategies of the oral anaerobe, Porphyromonas gingivalis. Trends Microbiol 1995;3:45-51.
43. Reidy MA, Bowyer DE. Distortion of endothelial repair. The effect of hypercholesterolemia on regeneration of aortic endothelium following injury by endotoxin. A scanning electron microscope study. Atherosclerosis 1978;29:459-466. (Pubitemid 8344167)
44. Van Lenten BJ, Fogelman AM, Seager J, Ribi E, Haberland ME, Edwards PA. Bacterial endotoxin selectively prevents the expression of scavenger-receptor activity on human monocyte-macrophages. J Immunol 1985;134:3718-3721. (Pubitemid 15034379)
45. Van Lenten BJ, Fogelman AM, Haberland ME, Edwards PA. The role of lipoproteins and receptormediated endocytosis in the transport of bacterial lipopolysaccharide. Proc Natl Acad Sci USA 1986; 83:2704-2708. (Pubitemid 16026952)
46. 2, and cytokine levels in patients with sepsis. Res Commun Chem Pathol Pharmacol 1994; 83:289-295.
47. Dohrn B. The investigations on the activity of plasma platellet activating factor-acetylhydrolase in patients with sepsis (in German). [Thesis]. Jena, Germany: Medical Faculty of the Friedrich-Schiller-University; 2000.
48. 2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Circulation 2004;109:837-842. (Pubitemid 38252734)
49. 2: An independent predictor of cardiovascular risk and a novel target for immunomodulation therapy. Cardiol Rev 2009;17:222-229.
50. Quist-Paulsen P. Statins and inflammation: An update. Curr Opin Cardiol 2010;25:399-405.